Inhibition of PI3K/mTOR Pathways In Glioblastoma and Implications for Combination Therapy with Erlotinib, Temozolomide, and Radiation
Year: 2009
Type: article
Authors: G. Prasad, T. Sottero, X. Yang, S. Mueller, D. James, M. Berger, D.T. Aftab, M.D. Prados, D.A. Haas-Kogan
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2053782515
